Register Login
Register to leave comments
  • News bot Jan. 12, 2026, 10:24 p.m.

    🔍 Boulding Mark Elliott (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 6,347

    Detailed Transactions and Holdings:

    • Sold 2,482 shares of Common Stock at $76.56 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 115,177.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 265 shares of Common Stock at $77.07 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 114,912.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,286 shares of Common Stock at $76.45 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,626.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 1,521 shares of Common Stock at $77.46 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 112,105.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 686 shares of Common Stock at $78.71 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 111,419.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 107 shares of Common Stock at $79.52 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 111,312.00 | transaction_form_type: 4 | Footnotes: F1, F7

    Footnotes:

    • F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.
    • F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.95 to $76.92 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.99 to $77.23 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F4: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.
    • F5: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.12 to $78.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F6: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.23 to $79.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F7: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.35 to $79.60 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Search

News categories